South Korea has secured additional new coronavirus vaccines for 23 million people by signing contracts with U.S. drugmakers Novavax and Pfizer, Prime Minister Chung Sye-kyun said Tuesday, according to Yonhap News Agency. Through the deals, Novavax will provide vaccines for 20 million people, which are expected to be ready for inoculation by the second quarter, and Pfizer will ship vaccines for 3 million also during the second quarter, Chung said during an interagency meeting on the nation's coronavirus response at the government complex in Sejong. Following the new deals, the government has secured COVID-19 vaccines to inoculate 79 million people under the World Health Organization's global vaccine COVAX Facility project and separate contracts with foreign drug firms.